4 unknown. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD GH509, Placebo - NASH, NAFLD | Phase 1 / Phase 2 | Unknown | 1Globe Biomedical Co., Ltd. | 180 | 2023-02-28 | 2023-03-28 |
| A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis Rencofilstat, Placebo - Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver | Phase 2 | Unknown | Hepion Pharmaceuticals, Inc. | 120 | 2022-10-15 | 2024-05-03 |
| Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH MET409 Active, MET409 Placebo, Empagliflozin - NASH, NASH - Nonalcoholic Steatohepatitis | Phase 2 | Unknown | Metacrine, Inc. | 120 | 2020-12-15 | 2021-06-01 |
| Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment Specialized product for medical nutrition (SPP-1), individualized diet - NAFLD, NASH - Nonalcoholic Steatohepatitis | Phase 2 / Phase 3 | Unknown | Russian Academy of Medical Sciences | 45 | 2020-03-20 | 2021-02-03 |
Non-alcoholic Fatty Liver Disease (4) · Fatty Liver (2) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Liver Cirrhosis (1)
Digestive System Diseases (4) · Liver Diseases (4) · Fatty Liver (2) · Endocrine System Diseases (1) · Fibrosis (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
CRV-431 (1) · empagliflozin (1)
1Globe Biomedical Co., Ltd. (1) · Hepion Pharmaceuticals, Inc. (1) · Metacrine, Inc. (1) · Russian Academy of Medical Sciences (1)
United States (2) · China (1) · France (1) · Mexico (1) · Russia (1)
Hubert C Chen, MD (1) · Stephen Harrison, MD (1) · Vasily Isakov, Professor (1)